View larger version (35K):
|
A 13-year-old girl with a 20-month history of type 1 diabetes mellitus presented with depressed areas of skin at the sites of insulin injection (Panel A, arrows). The patient had been treated since diagnosis with injections of biphasic insulin lispro (Humalog Mix 25, Eli Lilly) into both thighs. The physical examination and axial magnetic resonance imaging of the right thigh showed a loss of the adipose tissue layer at the injection sites. One injection site is shown in Panel B (arrow). Injection-site lipoatrophy is a recognized complication that is associated with all types of insulin and that has an estimated . . . [Full Text of this Article] |
Previous
